Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Paraneoplastic syndrome that involves the hematopoietic system.
Biomarker and diagnostic research for paraneoplastic hematological syndrome has been reported in the published literature.
No clinical trials have been registered for paraneoplastic hematological syndrome.
174 publications have been identified in PubMed for paraneoplastic hematological syndrome. Kisho has analyzed 54 by research type. Research spans Review / Meta-Analysis (43%), Case Report / Case Series (43%), and Diagnostic / Biomarker (4%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 23 | 43% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 3:32 AM UTC
Patient case studies |
23 |
43% |
Testing and diagnosis research | 2 | 4% |
Laboratory research | 2 | 4% |
Disease patterns and progression | 2 | 4% |
New treatment approaches | 2 | 4% |
Turna ZH (2026). [PMID: 41342788](https://pubmed.ncbi.nlm.nih.gov/41342788/). *Curr Opin Rheumatol*. [Review / Meta-Analysis]
Gonçalves TAP (2026). [PMID: 41617534](https://pubmed.ncbi.nlm.nih.gov/41617534/). *J Neurol Neurosurg Psychiatry*. [Review / Meta-Analysis]
Thapa B (2026). [PMID: 29939667](https://pubmed.ncbi.nlm.nih.gov/29939667/). *Unknown Journal*. [Review / Meta-Analysis]
Abu-Remaileh M (2026). [PMID: 41315757](https://pubmed.ncbi.nlm.nih.gov/41315757/). *Nat Med*. [Gene Therapy / Novel Therapeutics]
Salihoglu A (2026). [PMID: 41208292](https://pubmed.ncbi.nlm.nih.gov/41208292/). *Curr Opin Rheumatol*. [Review / Meta-Analysis]
Royal V (2026). [PMID: 40267904](https://pubmed.ncbi.nlm.nih.gov/40267904/). *Am J Nephrol*. [Review / Meta-Analysis]
Canaslan K (2026). [PMID: 41843177](https://pubmed.ncbi.nlm.nih.gov/41843177/). *Cancer Immunol Immunother*. [Review / Meta-Analysis]
Gaston J (2026). [PMID: 41134711](https://pubmed.ncbi.nlm.nih.gov/41134711/). *Clin Exp Dermatol*. [Review / Meta-Analysis]
Fan M (2026). [PMID: 42147214](https://pubmed.ncbi.nlm.nih.gov/42147214/). *Front Oncol*. [Case Report / Case Series]
Mal A (2025). [PMID: 41065553](https://pubmed.ncbi.nlm.nih.gov/41065553/). *Cancer Discov*. [Basic Science / Preclinical]